GlassScriptPhysician profile
Jayadeep Varanasi
NPI 1356355648
$6,698.44
in general payments reported to CMS, 2019-2025
36 companies · $976 in 2025
The $976 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $850 · 2020: $260 · 2021: $287 · 2022: $1,191 · 2023: $2,618 · 2024: $516 · 2025: $976.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,043 · Travel and Lodging: $1,067.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,043.36 |
| Travel and Lodging | $1,066.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,487.54 | 2022-2025 | Avvigo Guidance System, Eluvia |
| Abiomed | $738.76 | 2019-2023 | Impella |
| Amgen INC. | $454.27 | 2019-2025 | Repatha, Repatha |
| Medtronic, INC. | $406.52 | 2023-2025 | Micra, Onyx Frontier |
| Abbott Laboratories | $357.59 | 2019-2023 | Optis, Diamondback Coronary |
| Shockwave Medical, INC | $308.89 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $300.47 | 2019-2022 | |
| Teleflex LLC | $282.47 | 2019-2023 | Trapliner |
| Edwards Lifesciences Corporation | $241.51 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $172.30 | 2019-2023 | Lifevest |
| Biotronik INC. | $171.44 | 2024-2025 | Amvia Edge, Biomonitor |
| Janssen Pharmaceuticals, INC | $164.41 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $155.37 | 2019-2024 | Jardiance |
| Zoll Circulation INC | $146.56 | 2023 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| Pfizer INC. | $140.67 | 2019-2024 |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayadeep Varanasi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.